Year |
Citation |
Score |
2016 |
Moerke N, Fallahi-Sichani M. Reverse Phase Protein Arrays for Compound Profiling. Current Protocols in Chemical Biology. 8: 179-196. PMID 27622568 DOI: 10.1002/Cpch.9 |
0.358 |
|
2015 |
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You MH, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke NJ, Cao S, Reschke M, et al. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nature Medicine. 21: 457-66. PMID 25849135 DOI: 10.1038/Nm.3839 |
0.344 |
|
2015 |
Fallahi-Sichani M, Moerke NJ, Niepel M, Zhang T, Gray NS, Sorger PK. Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis. Molecular Systems Biology. 11: 797. PMID 25814555 DOI: 10.15252/Msb.20145877 |
0.323 |
|
2014 |
Beauchemin C, Moerke NJ, Faloon P, Kaye KM. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes. Journal of Biomolecular Screening. 19: 947-958. PMID 24518064 DOI: 10.1177/1087057114520973 |
0.38 |
|
2013 |
Tang Y, Xie T, Florian S, Moerke N, Shamu C, Benes C, Mitchison TJ. Differential determinants of cancer cell insensitivity to antimitotic drugs discriminated by a one-step cell imaging assay. Journal of Biomolecular Screening. 18: 1062-71. PMID 23788527 DOI: 10.1177/1087057113493804 |
0.326 |
|
2013 |
Fallahi-Sichani M, Moerke NJ, Dastur A, Benes CH, Sorger PK. Abstract 5213: A systems biology approach to understanding differential phenotypic outcome of BRAF(V600E) inhibition in melanoma cells. Cancer Research. 73: 5213-5213. DOI: 10.1158/1538-7445.Am2013-5213 |
0.378 |
|
2011 |
Moerke NJ, Hoffman GR. Development of in-cell Western assays using far-red fluorophores. Current Protocols in Chemical Biology. 3: 39-52. PMID 23836588 DOI: 10.1002/9780470559277.Ch100153 |
0.346 |
|
2011 |
Hoeffer CA, Cowansage KK, Arnold EC, Banko JL, Moerke NJ, Rodriguez R, Schmidt EK, Klosi E, Chorev M, Lloyd RE, Pierre P, Wagner G, LeDoux JE, Klann E. Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidation. Proceedings of the National Academy of Sciences of the United States of America. 108: 3383-8. PMID 21289279 DOI: 10.1073/Pnas.1013063108 |
0.486 |
|
2010 |
Hoffman GR, Moerke NJ, Hsia M, Shamu CE, Blenis J. A high-throughput, cell-based screening method for siRNA and small molecule inhibitors of mTORC1 signaling using the In Cell Western technique. Assay and Drug Development Technologies. 8: 186-99. PMID 20085456 DOI: 10.1089/Adt.2009.0213 |
0.341 |
|
2009 |
Moerke NJ. Fluorescence Polarization (FP) Assays for Monitoring Peptide-Protein or Nucleic Acid-Protein Binding. Current Protocols in Chemical Biology. 1: 1-15. PMID 23839960 DOI: 10.1002/9780470559277.Ch090102 |
0.402 |
|
2007 |
Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A, Gross JD, Degterev A, Yuan J, Chorev M, Halperin JA, Wagner G. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell. 128: 257-67. PMID 17254965 DOI: 10.1016/J.Cell.2006.11.046 |
0.639 |
|
2006 |
von der Haar T, Oku Y, Ptushkina M, Moerke N, Wagner G, Gross JD, McCarthy JE. Folding transitions during assembly of the eukaryotic mRNA cap-binding complex. Journal of Molecular Biology. 356: 982-92. PMID 16405910 DOI: 10.1016/J.Jmb.2005.12.034 |
0.639 |
|
2004 |
Natarajan A, Moerke N, Fan YH, Chen H, Christ WJ, Wagner G, Halperin JA. Synthesis of fluorescein labeled 7-methylguanosinemonophosphate. Bioorganic & Medicinal Chemistry Letters. 14: 2657-60. PMID 15109672 DOI: 10.1016/J.Bmcl.2004.02.090 |
0.531 |
|
2003 |
Gross JD, Moerke NJ, von der Haar T, Lugovskoy AA, Sachs AB, McCarthy JE, Wagner G. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E. Cell. 115: 739-50. PMID 14675538 DOI: 10.1016/S0092-8674(03)00975-9 |
0.58 |
|
Show low-probability matches. |